Contribution of DNA damage repair gene mutations and concomitant TP53 variations to the efficacy of platinum-based chemotherapy as initial therapeutic option in Chinese NSCLC patients
第一作者机构：[1]Sichuan Canc Hosp & Inst, Chengdu, Peoples R China[2]BGI Shenzhen, Shenzhen, Peoples R China
推荐引用方式(GB/T 7714)：
Ma Ke,Peng Jun,Zhang Huachuan,et al.Contribution of DNA damage repair gene mutations and concomitant TP53 variations to the efficacy of platinum-based chemotherapy as initial therapeutic option in Chinese NSCLC patients[J].JOURNAL OF CLINICAL ONCOLOGY.2020,38(15):doi:10.1200/JCO.2020.38.15_suppl.e21002.
APA：
Ma, Ke,Peng, Jun,Zhang, Huachuan,He, Jintao,Xiao, Bo...&Rong, Hao.(2020).Contribution of DNA damage repair gene mutations and concomitant TP53 variations to the efficacy of platinum-based chemotherapy as initial therapeutic option in Chinese NSCLC patients.JOURNAL OF CLINICAL ONCOLOGY,38,(15)
MLA：
Ma, Ke,et al."Contribution of DNA damage repair gene mutations and concomitant TP53 variations to the efficacy of platinum-based chemotherapy as initial therapeutic option in Chinese NSCLC patients".JOURNAL OF CLINICAL ONCOLOGY 38..15(2020)
医学